Terms: = Prostate cancer AND RUNX1T1, ENSG00000079102, 862 AND Treatment
25 results:
1. Causes of Death after prostate cancer Diagnosis: A Population-Based Study.
Guo Y; Dong X; Mao S; Yang F; Wang R; Ma W; Liu J; Li C; Zheng Z; Zhang W; Zhang A; Yao X
Oxid Med Cell Longev; 2022; 2022():8145173. PubMed ID: 35502209
[TBL] [Abstract] [Full Text] [Related]
2. Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
[TBL] [Abstract] [Full Text] [Related]
3. Population-Level Uptake of Moderately Hypofractionated Definitive Radiation Therapy in the treatment of prostate cancer.
Nithiyananthan K; Creighton N; Currow D; Martin JM
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):417-423. PubMed ID: 33974884
[TBL] [Abstract] [Full Text] [Related]
4. Patterns and characteristics of patients' selection of cancer surgeons.
Del Vecchio NJ; Askelson NM; Carter KD; Chrischilles E; Lynch CF; Charlton ME
Am J Surg; 2021 May; 221(5):1033-1041. PubMed ID: 33969822
[TBL] [Abstract] [Full Text] [Related]
5. Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive prostate cancer.
Parikh NR; Chang EM; Nickols NG; Rettig MB; Raldow AC; Steinberg ML; Koontz BF; Vapiwala N; Deville C; Feng FY; Spratt DE; Reiter RE; Phillips R; Ost P; Tran PT; Kishan AU
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):917-926. PubMed ID: 32544574
[TBL] [Abstract] [Full Text] [Related]
6. Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study.
Zapatero A; Gómez-Caamaño A; Cabeza Rodriguez MÁ; Muinelo-Romay L; Martin de Vidales C; Abalo A; Calvo Crespo P; Leon Mateos L; Olivier C; Vega Piris LV
Radiat Oncol; 2020 Jun; 15(1):137. PubMed ID: 32487218
[TBL] [Abstract] [Full Text] [Related]
7. Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potential.
Waingankar N; Martini A; Griffiths L; Shah P; Paulucci DJ; Kotamarti S; Gul Z; Elmasri M; Yaskiv O; Haines K; Lerner S; Vira M; Kavoussi LR; Tewari AK; Kapoor DA; Olsson CA
Urol Oncol; 2020 Mar; 38(3):78.e15-78.e21. PubMed ID: 31796374
[TBL] [Abstract] [Full Text] [Related]
8. Disparities in surgery for early-stage cancer: the impact of refusal.
Rapp J; Tuminello S; Alpert N; Flores RM; Taioli E
Cancer Causes Control; 2019 Dec; 30(12):1389-1397. PubMed ID: 31630307
[TBL] [Abstract] [Full Text] [Related]
9. Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional cancer Hospital (SEARCH) database.
Herforth C; Stroup SP; Chen Z; Howard LE; Freedland SJ; Moreira DM; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ
BJU Int; 2018 Oct; 122(4):592-598. PubMed ID: 29473992
[TBL] [Abstract] [Full Text] [Related]
10. Metformin Reduces prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways.
Sarmento-Cabral A; L-López F; Gahete MD; Castaño JP; Luque RM
Mol Cancer Res; 2017 Jul; 15(7):862-874. PubMed ID: 28385910
[TBL] [Abstract] [Full Text] [Related]
11. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
12. Coumestrol Inhibits Proliferation and Migration of prostate cancer Cells by Regulating AKT, ERK1/2, and JNK MAPK Cell Signaling Cascades.
Lim W; Jeong M; Bazer FW; Song G
J Cell Physiol; 2017 Apr; 232(4):862-871. PubMed ID: 27431052
[TBL] [Abstract] [Full Text] [Related]
13. Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging.
Muralidhar V; Dinh KT; Mahal BA; Ziehr DR; Chen YW; Viswanathan VB; Nezolosky MD; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jul; 33(7):330.e19-25. PubMed ID: 25990612
[TBL] [Abstract] [Full Text] [Related]
14. Reliability, Validity, and Minimal Detectable Change of Balance Evaluation Systems Test and Its Short Versions in Older cancer Survivors: A Pilot Study.
Huang MH; Miller K; Smith K; Fredrickson K; Shilling T
J Geriatr Phys Ther; 2016; 39(2):58-63. PubMed ID: 25695466
[TBL] [Abstract] [Full Text] [Related]
15. Gleason Upgrading with Time in a Large prostate cancer Active Surveillance Cohort.
Jain S; Loblaw A; Vesprini D; Zhang L; Kattan MW; Mamedov A; Jethava V; Sethukavalan P; Yu C; Klotz L
J Urol; 2015 Jul; 194(1):79-84. PubMed ID: 25660208
[TBL] [Abstract] [Full Text] [Related]
16. NADiA ProsVue prostate-specific antigen slope, CAPRA-S, and prostate cancer--specific survival after radical prostatectomy.
Moul JW; Sarno MJ; McDermed JE; Triebell MT; Reynolds MA
Urology; 2014 Dec; 84(6):1427-32. PubMed ID: 25432832
[TBL] [Abstract] [Full Text] [Related]
17. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
Dearnaley DP; Jovic G; Syndikus I; Khoo V; Cowan RA; Graham JD; Aird EG; Bottomley D; Huddart RA; Jose CC; Matthews JH; Millar JL; Murphy C; Russell JM; Scrase CD; Parmar MK; Sydes MR
Lancet Oncol; 2014 Apr; 15(4):464-73. PubMed ID: 24581940
[TBL] [Abstract] [Full Text] [Related]
18. The economic burden of prostate cancer.
Roehrborn CG; Black LK
BJU Int; 2011 Sep; 108(6):806-13. PubMed ID: 21884356
[TBL] [Abstract] [Full Text] [Related]
19. α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study.
Barry M; Dhillon PK; Stampfer MJ; Perner S; Ma J; Giovannucci E; Kurth T; Mucci LA; Rubin MA
Prostate; 2012 Feb; 72(3):301-6. PubMed ID: 21713964
[TBL] [Abstract] [Full Text] [Related]
20. Potential clinical applications of epothilones: a review of phase II studies.
Larkin JM; Kaye SB
Ann Oncol; 2007 Jul; 18 Suppl 5():v28-34. PubMed ID: 17656559
[TBL] [Abstract] [Full Text] [Related]
[Next]
